An integrated approach to evaluate different tetracycline derivatives for formulary decisions. (27th November 2021)
- Record Type:
- Journal Article
- Title:
- An integrated approach to evaluate different tetracycline derivatives for formulary decisions. (27th November 2021)
- Main Title:
- An integrated approach to evaluate different tetracycline derivatives for formulary decisions
- Authors:
- Zidaru, Andrei
Phe, Kady
Lasco, Todd M
Tam, Vincent H - Abstract:
- Abstract: Purpose: Stenotrophomonas maltophilia has emerged as a critical opportunistic pathogen associated with significant morbidity and mortality. Tetracycline derivatives have been recognized as alternative treatment options, but they have varied pharmacokinetic properties. An integrated approach to different tetracycline derivatives for formulary decisions is reported. Methods: The minimum inhibitory concentration (MIC) data from clonally diverse bloodstream S. maltophilia isolates were examined, along with the pharmacokinetic profiles of 4 tetracycline derivatives, to predict achievable pharmacodynamic exposures with standard intravenous dosing regimens. Antimicrobial therapy was assessed using the ratio of daily drug acquisition cost relative to the ratio of the free-drug area under the time-concentration curve ( f AUC) to minimum inhibitory concentration (MIC) for 90% of isolates ( f AUC/MIC90 ). Results: In our analysis, minocycline had the greatest f AUC/MIC90 . Doxycycline was the most financially preferred agent, as calculated using 2020 average wholesale price for base-case estimates of drug acquisition cost. Conclusion: An integrated evaluation for antimicrobial formulary decision-making addressed local susceptibility data, pharmacokinetics, pharmacodynamics, dosing regimens, and drug acquisition costs. This comprehensive method is more objective than the conventional approach and warrants validation.
- Is Part Of:
- American journal of health-system pharmacy. Volume 79:Number 6(2022)
- Journal:
- American journal of health-system pharmacy
- Issue:
- Volume 79:Number 6(2022)
- Issue Display:
- Volume 79, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 79
- Issue:
- 6
- Issue Sort Value:
- 2022-0079-0006-0000
- Page Start:
- 467
- Page End:
- 471
- Publication Date:
- 2021-11-27
- Subjects:
- anti-infective agents -- doxycycline -- drug evaluation -- eravacycline -- minocycline -- omadacycline
Hospital pharmacies -- United States -- Periodicals
615.1 - Journal URLs:
- https://academic.oup.com/ajhp ↗
http://www.oxfordjournals.org/ ↗ - DOI:
- 10.1093/ajhp/zxab451 ↗
- Languages:
- English
- ISSNs:
- 1079-2082
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25783.xml